Search

Your search keyword '"Sonali, Palkar"' showing total 61 results

Search Constraints

Start Over You searched for: Author "Sonali, Palkar" Remove constraint Author: "Sonali, Palkar"
61 results on '"Sonali, Palkar"'

Search Results

1. Neutralizing Antibodies against 10 SARS-CoV-2 Variants at Two Years Post-COVISHIELD Vaccination with Special Reference to Omicron Subvariants and Booster Administration

2. Platelet derived exosomes disrupt endothelial cell monolayer integrity and enhance vascular inflammation in dengue patients

3. Variable neutralizing antibody responses to 10 SARS-CoV-2 variants in natural infection with wild- type (B.1) virus, Kappa (B.1.617.1), and Delta (B.1.617.2) variants and COVISHIELD vaccine immunization in India: utility of the MSD platform

4. A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months

5. Immunogenicity of two COVID-19 vaccines used in India: An observational cohort study in health care workers from a tertiary care hospital

6. Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal

7. Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity

8. Prevalence and determinants of undernutrition among under-five children residing in urban slums and rural area, Maharashtra, India: a community-based cross-sectional study

9. Elevated Levels of Neutrophil Activated Proteins, Alpha-Defensins (DEFA1), Calprotectin (S100A8/A9) and Myeloperoxidase (MPO) Are Associated With Disease Severity in COVID-19 Patients

10. Prevalence of the Acute Respiratory Infections and Associated Factors in the Rural Areas and Urban Slum Areas of Western Maharashtra, India: A Community-Based Cross-Sectional Study

11. Characterization of Bordetella pertussis Strains Isolated from India

12. Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age

13. A Study of the Clinico-epidemiological Profile of COVID-19 Patients Admitted in a Tertiary Care Hospital in India

14. Association of preeclampsia with anthropometric measures and blood pressure in Indian children.

15. Reported incidence and risk factors of childhood pneumonia in India: a community-based cross-sectional study

16. Clinical study of safety and immunogenicity of pentavalent DTP-HB-Hib vaccine administered by disposable-syringe jet injector in India

17. Safety and immunogenicity of an investigational meningococcal ACWY conjugate vaccine (MenACWY-CRM) in healthy Indian subjects aged 2 to 75 years

18. Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from India

19. Isolation and genetic characterization of SARS-CoV-2 from Indian patients in a single family without H/O travel abroad

20. Challenges and opportunities in setting up a phase III vaccine clinical trial in resource limited settings: Experience from Nepal

21. Performance assessment of SARS-CoV-2 IgM & IgG ELISAs in comparison with plaque reduction neutralization test

22. Characterization of

23. Model package of Behavioral Change Communication regarding childhood pneumonia and its risk factors: a pre-post assessment

25. Effect of Behavior Change Communication on the Incidence of Pneumonia in Under Five Children: A Cluster Randomized Controlled Trial

26. Prevalence of the Acute Respiratory Infections and Associated Factors in the Rural Areas and Urban Slum Areas of Western Maharashtra, India: A Community-Based Cross-Sectional Study

27. Meager Perception of Preconception Care Among Women Desiring Pregnancy in Rural Areas: A Qualitative Study Using Focus Group Discussions

28. Association between adverse pregnancy outcomes and preceding risk factors: a cross-sectional study from Nashik District, India

29. Seroepidemiology of respiratory syncytial virus in western India with special reference to appropriate age for infant vaccination

30. Immunogenicity and lot-to-lot consistency of a ready to use liquid bovine-human reassortant pentavalent rotavirus vaccine (ROTASIIL - Liquid) in Indian infants

31. Early disappearance of maternal anti-measles, mumps, rubella, and varicella antibodies in Indian infants

32. Association Between Adverse Pregnancy Outcomes and Preceding Risk Factors: an Analytical Cross-Sectional Study

33. Immune Response of Indian Preterm Infants to Pentavalent Vaccine Varies With Component Antigens and Gestational Age

34. Prevalence of Preconception Risk Factors Among Women From Tribal and Non-tribal Blocks in Nashik District, India: A Cross-Sectional Study

35. Antibody (IgA, IgG, and IgG Subtype) Responses to SARS-CoV-2 in Severe and Nonsevere COVID-19 Patients

36. Disease‐duration based comparison of subsets of immune cells in SARS CoV‐2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severity

37. Immunogenicity of Two COVID-19 Vaccines Currently Used in India: Experience in Health Care Workers From a Tertiary Care Hospital

38. Prevalence and determinants of undernutrition among under-five children residing in urban slums and rural area, Maharashtra, India: a community-based cross-sectional study

39. Health risks among women desiring pregnancy within one year: a cross-sectional study in Maharashtra India

40. ­Knowledge and behaviour about preconception care among women desiring conception, from tribal and non-tribal areas; a qualitative study using focused group discussions

41. Manuscript title: Prevalence and determinants of undernutrition among under-five children residing in urban slums and rural area, Maharashtra, India: a community-based cross-sectional study

42. Association of preeclampsia with anthropometric measures and blood pressure in Indian children

43. Prevalence and determinants of undernutrition among under-five children residing in urban slums and rural area, Maharashtra, India: a community based cross sectional study

44. Safety and immunogenicity of inactivated hepatitis-A vaccine developed by Human Biologicals Institute in two age groups of healthy subjects: A phase I open label study

45. Knowledge, Attitudes, and Practices Toward Coronavirus Disease 2019 Among People in a Tertiary Care Hospital in India

46. Response to: Letter from P. Gillard and B. Benninghoff

47. Anti-SARS-CoV-2 IgG antibody response among Indian COVID-19 patients using β-propiolactone-inactivated, whole virus-based indirect ELISA

48. Age-stratified anti-HAV positivity in Pune, India after two decades: Has voluntary vaccination impacted overall exposure to HAV?

49. Non-interference of Bovine-Human reassortant pentavalent rotavirus vaccine ROTASIIL® with the immunogenicity of infant vaccines in comparison with a licensed rotavirus vaccine

50. Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine

Catalog

Books, media, physical & digital resources